Novo Nordisk: Massive Overreaction Presents An Opportunity

Novo Nordisk ( NVO ) suddenly surprised the market with lowered expectations and a change in CEO. I wanted to go through the news and give my thoughts on the company’s overall potential. I think that was quite an overreaction, and the long-term performanceMSc in Finance. Long-term horizon investor mostly with 5-10 year horizon. I like to keep investing simple. I believe a portfolio should consist of a mix of growth, value, and dividend-paying stocks but usually end up looking for value more than anything. I ...